Pharmacology, Toxicology and Pharmaceutical Science
Human Papillomavirus
100%
Uterine Cervix Carcinoma in Situ
100%
Human Papillomavirus Type 16
50%
Uterine Cervix Cancer
40%
Human Papillomavirus Type 52
40%
Human Papillomavirus Type 18
20%
Human Papillomavirus Type 58
20%
Human Papillomavirus Type 33
20%
Prevalence
10%
Human Papillomavirus Type 31
10%
Biochemistry, Genetics and Molecular Biology
Genotyping
100%
Wart Virus
100%
Human Papillomavirus Type 16
50%
Human Papillomavirus Type 52
40%
Polymerase Chain Reaction
20%
Human Papillomavirus Type 18
20%
Human Papillomavirus Type 58
20%
Human Papillomavirus Type 33
20%
Prevalence
10%
Real-Time Polymerase Chain Reaction
10%
Human Papillomavirus Type 31
10%
Immunology and Microbiology
Wart Virus
100%
Human Papillomavirus Type 16
50%
Human Papillomavirus Type 52
40%
Polymerase Chain Reaction
20%
Human Papillomavirus Type 18
20%
Human Papillomavirus Type 58
20%
Human Papillomavirus Type 33
20%
Vaccine Efficacy
10%
Real Time Polymerase Chain Reaction
10%
Genotype
10%
Prevalence
10%
Human Papillomavirus Type 31
10%